3

PRIMARY DOCUMENT

Company: SELLAS Life Sciences Group, Inc.
Filed: March 1, 2013
Period of Report: March 1, 2013
Accession Number: 0001250853-13-000034

View Document ↗ View on SEC.gov ↗